Insider Strategies for Procuring Best-in-Class SIP Systems in Pharma

Picture this: It’s the 1940s. A pharmaceutical factory is producing penicillin. One round of production is just over and the workers are in the process of dismantling every pipe, piece of machinery, and process vessel that was used in the manufacturing process. Each of these will be manually cleaned and sterilised to adequate standards, to be put back together painstakingly before the production of the next batch of penicillin. Only for the facility’s workers to repeat the entire dismantling, cleaning, sterilising, and reassembly process all over again after this production run.

Aren’t you glad we have SIP systems now?

The decade after our imaginary scenario brought with it the SIP system, or sterilization in place – a game changer for the food and beverage and pharmaceutical industries which required frequent cleaning to adhere to stringent sanitary standards.

The manual method of going about sterilisation was just too cumbersome, labour intensive and time consuming. Not only did it introduce the possibility of contamination during reassembly, but it also took away from what could otherwise have been productive time for the equipment – be it a heat exchanger, compounding vessel, bio kill system, or bioreactor.

What is sterilisation in place?

Before we address the question of what SIP systems are, let us first understand what sterilisation is.

A device, product or piece of equipment is considered sterile when it has absolutely no trace of active microorganisms in it. The complete absence of bacteria, viruses, yeasts and other microbes is achieved via chemical, thermal, radiation or filtration methods – with the method selected depending on the physical properties of the material in question, like its heat stability and tolerance to chemicals. Regulatory acceptance criteria assess sterility based on calculated contamination probability.

Now, sterilisation in place refers to the in situ sterilisation of manufacturing equipment (and all allied elements in the system) without its disassembly. It is a critical aspect of meeting current Good Manufacturing Practice, or cGMP, requirements, and is particularly important in areas where germ reduction transforms the safety or efficacy of the final pharmaceutical preparation. Often carried out by means of superheated steam in the pharma, biotech and F&B industries, SIP systems permit the whole processing system to be treated as a single entity, minimising the need for aseptic connections and post-sterilisation handling.

An SIP system goes hand-in-hand with a CIP, or clean in place, system. SIP is ordinarily an extension of the CIP process, and ensures than any microorganisms still left behind in the system after CIP are eliminated with hot water, saturated pure steam at a temperature greater than 120°C, or whatever other mechanism is employed.

What does the sterilization in place process involve?

As we mentioned earlier, the specifics of the sterilization in place process vary depending on the mechanical properties of the equipment, the nature of the pharmaceutical preparation being produced, and the level of sterility demanded by the process.

In pharma and biotech, thermal sterilisation is fairly common. Industries may also rely on radiation sterilization via X-rays, electron beams, or gamma rays. Sterile filtration may rid the system of larger particulate and microbial contaminants. And when none of these methods is practical, those in sterile industries may rely on chemical sterilisation.

We’re sure you want to know more about the specifics of different methods, so let’s take a tiny glimpse into the mechanisms SIP systems may employ:

Steam (moist heat):

Thermal sterilisation is of more than one kind. Of these, steam is the most commonly used as an SIP system for large scale processes. Usually, bioreactors, holding vessels, sterile bulk production lines, and sterile delivery lines all use this form of SIP system. In all these cases, steam sterilisation is followed up with air removal, condensate discharge and steam removal – all usually automated, at least to some extent – to prevent post-SIP contamination.

Superheated water:

Water heated above its boiling point and pressurised in a way which maintains its liquid state is often used for sterilisation of purified water systems and water for injection. The superheated water is circulated through all the equipment, piping, vessels, filters and process components to rid them of any residual contaminants.

Dry heat:

Dry heat, meanwhile, is provided via HEPA filters for the sterilisation in place of pharmaceutical spray dryers.

Gas:

Equipment which cannot take high temperature-pressure sterilisation – these could be certain process vessels of freeze dryers – are subjected to gas-phase sterilisation using gases like ethylene oxide.

Chemical liquids:

Liquid chemical sterilisation in place is used only in those situations in which liquid sterilant toxicity is not a problem. It is employed only in systems in which internal surfaces can come in complete contact with the liquid sterilising chemical.

Chemical vapours:

Vapours of hydrogen peroxide or peracetic acid may be used in the same way as sterilising gases. When used, it is critical that off-gassing is also carried about appropriately so that toxic sterilising substances don’t contaminate the pharma equipment or product.

How to choose the best SIP system for pharma?

Understanding the sterilization in place process, as you have done so far in this blog post, is the first step towards making an informed SIP system procurement decision. But here are some more things to look out for, some insider strategies, that will help you make sure your SIP systems will, in fact, serve your facility’s purposes well and for a long time to come.

Combo CIP + SIP system

CIP and SIP systems go together. SIP is just a natural extension of the clean in place process, so always go for cleaning systems which integrate the two and minimise your and your staff’s work in the long run. Combos are the way to go!

Comprehensive sterilisation

Cleaning and sterilisation are holistic processes. You can’t sterilise your compounding vesselswithout also sterilising the holding vessels, process piping, valves, filters, hoses, skid components, and any other surface that your pharma preparation may come in contact with. This means that sterilisation may have to be carried out in sections, with adjacent sterilisation processes overlapping, so that not a single spot is missed. Comprehensive sterilisation will keep your product safe from cross-contamination from prior batch residue, cleaning agents, and cell debris.

Design considerations

You want to ensure that the SIP systems you invest in are intelligently designed. There are tiny design considerations that reveal a manufacturer’s attention to detail. These include static or dynamic spray balls which work together with desired temperatures, spray concentrations, and time duration. Also, the system should ideally include mechanisms for complete displacement of entrapped air and elimination of condensate build up. Customisations which include single or multiple tank and pump design also allow you to tailor the system to perfectly suit your needs.

Complete qualification and validation package

It’s not important that your equipment manufacturer only claims that they have what it takes to meet your SIP system needs. Make sure you go for a manufacturer who provides you with complete validation documentation, facilities for cleanroom FAT, as well as the life-cycle benefits of Annual Maintenance Contracts, or AMCs, and the provision of spares as and when needed. Your purchase of an SIP system should not be the end of your journey with your supplier; in fact, it can be the beginning of a long, fruitful partnership to maintain the sterile integrity of your facility and products. TSA provides best-in-class CIP and SIP systems for all your pharma, biotech and other sterile manufacturing needs. We love a good process or high purity challenge, and we would love to wrack our brains about yours. Reach out to us today.

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.